Skip to main content

Gadobutrol

HealthData.Gov

Updated Oct 29, 2026

About this dataset

Gadobutrol is a prescription intravenous contrast agent used to enhance magnetic resonance imaging (MRI) scans, helping doctors visualize body structures more clearly. Manufactured by Fresenius Kabi USA, LLC, it's available in solution form with a concentration of 604.72 mg/mL in vials of 2 mL, 7.5 mL, 10 mL, or 15 mL. This gadolinium-based drug works by improving MRI contrast for better diagnosis. This information was generated using AI and is provided for informational and research purposes only.

Data and resources (1)

  • HTML

    Gadobutrol

    Access the FDA dataset for Gadobutrol — ANDA 216081 submitted by Mylan Institutional LLC

    Modified Apr 29, 2026

Prototype by Datopian · not an official government website · data from data.virginia.gov